Investing News NetworkNovember 20, 2024Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) is proud to announce the publication of a pivotal research article in the prestigious Journal of Cosmetic Dermatology . About the Study The article, titled 'TFC-1326 Compound Reduces Clinical Signs of Skin Aging: Evidence From In Vitro Human Adipose and Skin Models and Pilot Clinical Trial,' highlights the groundbreaking efficacy of Sirona's proprietary compound TFC-1326 in reducing visible signs of skin aging.

投资新闻网2024年11月20日Sirona Biochem Corp.（TSX-V:SBM）（FSE:ZSB）骄傲地宣布在著名的《美容皮肤病学杂志》上发表一篇关键研究文章。关于这项研究，这篇题为“TFC-1326化合物减少皮肤衰老的临床症状：来自体外人类脂肪和皮肤模型和初步临床试验的证据”的文章强调了Sirona专有化合物TFC-1326在减少可见皮肤衰老迹象方面的开创性功效。

Read the full article here: Access the Study: TFC-1326 Compound Reduces Clinical Signs of Skin Aging. Evidence From In Vitro Human Adipose and Skin Models and Pilot Clinical Trial The study, conducted by leading scientists at Diva Expertise in collaboration with Sirona Biochem, presents compelling data demonstrating the ability of TFC-1326 to target key mechanisms of skin aging.

阅读全文：访问研究：TFC-1326化合物可减少皮肤衰老的临床症状。。

Key Findings Using advanced in vitro human adipose and skin models, as well as a pilot clinical trial, TFC-1326 was shown to: Enhance skin elasticity and firmness Stimulate the production of collagen and other extracellular matrix components Reduce the appearance of fine lines and wrinkles Clinical Trial Results The pilot clinical trial with a 1% TFC-1326 topical cream provided robust evidence supporting its safety and efficacy.

主要发现使用先进的体外人体脂肪和皮肤模型以及初步临床试验，TFC-1326被证明可以增强皮肤弹性和硬度，刺激胶原蛋白和其他细胞外基质成分的产生，减少细纹和皱纹的出现。临床试验结果使用1%TFC-1326外用乳膏进行的初步临床试验提供了强有力的证据，支持其安全性和有效性。

Key results included: Visible improvement in skin texture, hydration, and overall appearance These findings reinforce the compound's potential as a next-generation anti-aging solution. Statements from Leadership 'Our innovative approach to carbohydrate chemistry has once again delivered transformative results,' said Dr.

主要结果包括：皮肤质地，水合作用和整体外观的明显改善这些发现增强了该化合物作为下一代抗衰老溶液的潜力。领导层的声明“我们对碳水化合物化学的创新方法再次带来了变革性的结果，”博士说。

Howard Verrico, CEO of Sirona Biochem. 'The publication of these findings in the Journal of Cosmetic Dermatology is a testament to the cosmeceut.

Sirona Biochem首席执行官霍华德·维里科（HowardVerrico）这些发现在《美容皮肤病学杂志》上的发表是对药妆品的证明。